CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders.

Ewa Gibula-Tarlowska; Volker Korz; Malgorzata Lopatynska-Mazurek; Agnieszka Chlopas-Konowalek; Pawel Grochecki; Predrag Kalaba; Vladimir Dragacevic; Robert Kotlinski; Radosław Kujawski; Michał Szulc; Kamila Czora-Poczwardowska; Przemyslaw L Mikolajczak; Gert Lubec; Jolanta H Kotlinska

doi:10.1016/j.bbr.2021.113326

CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders.

Ewa Gibula-Tarlowska, Volker Korz, Malgorzata Lopatynska-Mazurek, Agnieszka Chlopas-Konowalek, Pawel Grochecki, Predrag Kalaba, Vladimir Dragacevic, Robert Kotlinski, Radosław Kujawski, Michał Szulc, Kamila Czora-Poczwardowska, Przemyslaw L Mikolajczak, Gert Lubec (Co-Autor/-in), Jolanta H Kotlinska

Forschungsprogramm für Proteomics

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

11 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	113326
Fachzeitschrift	BEHAVIOURAL BRAIN RESEARCH
Jahrgang	410
DOIs	https://doi.org/10.1016/j.bbr.2021.113326
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1016/j.bbr.2021.113326

Dieses zitieren

Gibula-Tarlowska, E., Korz, V., Lopatynska-Mazurek, M., Chlopas-Konowalek, A., Grochecki, P., Kalaba, P., Dragacevic, V., Kotlinski, R., Kujawski, R., Szulc, M., Czora-Poczwardowska, K., Mikolajczak, P. L., Lubec, G., & Kotlinska, J. H. (2021). CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders. BEHAVIOURAL BRAIN RESEARCH , 410, 113326. https://doi.org/10.1016/j.bbr.2021.113326

Gibula-Tarlowska, Ewa ; Korz, Volker ; Lopatynska-Mazurek, Malgorzata et al. / CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders. in: BEHAVIOURAL BRAIN RESEARCH 2021 ; Jahrgang 410. S. 113326.

@article{b02efafd5a1345468c5cc0ca5e10330a,

title = "CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders.",

keywords = "ATTENTION-DEFICIT HYPERACTIVITY, PRENATAL ETHANOL EXPOSURE, BRAIN GROWTH, NORADRENERGIC NEURONS, PREFRONTAL CORTEX, SPATIAL MEMORY, IN-UTERO, CHILDREN, METHYLPHENIDATE, MAZE",

author = "Ewa Gibula-Tarlowska and Volker Korz and Malgorzata Lopatynska-Mazurek and Agnieszka Chlopas-Konowalek and Pawel Grochecki and Predrag Kalaba and Vladimir Dragacevic and Robert Kotlinski and Rados{\l}aw Kujawski and Micha{\l} Szulc and Kamila Czora-Poczwardowska and Mikolajczak, {Przemyslaw L} and Gert Lubec and Kotlinska, {Jolanta H}",

note = "Lubec; Kalaba: Paracelsus Private Med Univ, Salzburg, Austria; ",

year = "2021",

doi = "10.1016/j.bbr.2021.113326",

language = "English",

volume = "410",

pages = "113326",

journal = "BEHAVIOURAL BRAIN RESEARCH ",

issn = "0166-4328",

}

Gibula-Tarlowska, E, Korz, V, Lopatynska-Mazurek, M, Chlopas-Konowalek, A, Grochecki, P, Kalaba, P, Dragacevic, V, Kotlinski, R, Kujawski, R, Szulc, M, Czora-Poczwardowska, K, Mikolajczak, PL, Lubec, G & Kotlinska, JH 2021, 'CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders.', BEHAVIOURAL BRAIN RESEARCH , Jg. 410, S. 113326. https://doi.org/10.1016/j.bbr.2021.113326

CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders. / Gibula-Tarlowska, Ewa; Korz, Volker; Lopatynska-Mazurek, Malgorzata et al.
in: BEHAVIOURAL BRAIN RESEARCH , Jahrgang 410, 2021, S. 113326.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders.

AU - Gibula-Tarlowska, Ewa

AU - Korz, Volker

AU - Lopatynska-Mazurek, Malgorzata

AU - Chlopas-Konowalek, Agnieszka

AU - Grochecki, Pawel

AU - Kalaba, Predrag

AU - Dragacevic, Vladimir

AU - Kotlinski, Robert

AU - Kujawski, Radosław

AU - Szulc, Michał

AU - Czora-Poczwardowska, Kamila

AU - Mikolajczak, Przemyslaw L

AU - Lubec, Gert

AU - Kotlinska, Jolanta H

N1 - Lubec; Kalaba: Paracelsus Private Med Univ, Salzburg, Austria;

PY - 2021

Y1 - 2021

KW - ATTENTION-DEFICIT HYPERACTIVITY

KW - PRENATAL ETHANOL EXPOSURE

KW - BRAIN GROWTH

KW - NORADRENERGIC NEURONS

KW - PREFRONTAL CORTEX

KW - SPATIAL MEMORY

KW - IN-UTERO

KW - CHILDREN

KW - METHYLPHENIDATE

KW - MAZE

U2 - 10.1016/j.bbr.2021.113326

DO - 10.1016/j.bbr.2021.113326

M3 - Original Article

C2 - 33940050

SN - 0166-4328

VL - 410

SP - 113326

JO - BEHAVIOURAL BRAIN RESEARCH

JF - BEHAVIOURAL BRAIN RESEARCH

ER -

Gibula-Tarlowska E, Korz V, Lopatynska-Mazurek M, Chlopas-Konowalek A, Grochecki P, Kalaba P et al. CE-123, a novel dopamine transporter inhibitor, attenuates locomotor hyperactivity and improves cognitive functions in rat model of fetal alcohol spectrum disorders. BEHAVIOURAL BRAIN RESEARCH . 2021;410:113326. doi: 10.1016/j.bbr.2021.113326